Cover
Cover | Mar. 01, 2022 |
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Mar. 1, 2022 |
Entity Registrant Name | NGM Biopharmaceuticals, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-38853 |
Entity Tax Identification Number | 26-1679911 |
Entity Address, Address Line One | 333 Oyster Point Boulevard |
Entity Address, City or Town | South San Francisco |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94080 |
City Area Code | 650 |
Local Phone Number | 243-5555 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.001 per share |
Trading Symbol | NGM |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Amendment Flag | false |
Entity Central Index Key | 0001426332 |